Portfolio Holdings Detail for ISIN IE000G2LIHG9

Stock Name / Fund	iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	SAUA(EUR) ETF Plus

Holdings detail for MRK

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45

IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06

Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation

(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21

Notable ETF Inflow Detected - VYM, JNJ, MRK, CME

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14

Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56

Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO

The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23

MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'

Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49

MRK Quantitative Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02

iShares MSCI ACWI ETF Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21

Dow Movers: WMT, MRK

In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00

After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ

The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59

Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan

(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey

Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00

Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59

Top Analyst Reports for Merck, Palo Alto & Freeport

Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33

MRK April 2026 Options Begin Trading

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc) MRK holdings

Date	Number of MRK Shares Held	Base Market Value of MRK Shares	Local Market Value of MRK Shares	Change in MRK Shares Held	Change in MRK Base Value	Current Price per MRK Share Held	Previous Price per MRK Share Held
2025-09-30 (Tuesday)	764,152	USD 64,135,277	USD 64,135,277	11,753	USD 5,011,764	USD 83.93	USD 78.58
2025-09-29 (Monday)	752,399	USD 59,123,513	USD 59,123,513	3,059	USD 255,363	USD 78.58	USD 78.56
2025-09-26 (Friday)	749,340	USD 58,868,150	USD 58,868,150	6,908	USD 1,255,427	USD 78.56	USD 77.6
2025-09-25 (Thursday)	742,432	USD 57,612,723	USD 57,612,723	483	USD -1,498,354	USD 77.6	USD 79.67
2025-09-24 (Wednesday)	741,949	USD 59,111,077	USD 59,111,077	9,156	USD -633,536	USD 79.67	USD 81.53
2025-09-18 (Thursday)	732,793	USD 59,744,613	USD 59,744,613	1,932	USD 442,551	USD 81.53	USD 81.14
2025-09-17 (Wednesday)	730,861	USD 59,302,062	USD 59,302,062	2,415	USD 232,376	USD 81.14	USD 81.09
2025-09-16 (Tuesday)	728,446	USD 59,069,686	USD 59,069,686	3,864	USD 364,052	USD 81.09	USD 81.02
2025-09-15 (Monday)	724,582	USD 58,705,634	USD 58,705,634

Share Trades of MRK by Blackrock for IE000G2LIHG9

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-09-30	BUY	11,753	84.000	78.400	78.960	GBX 928,017	88.77
2025-09-29	BUY	3,059	78.800	78.030	78.107	GBX 238,929	88.82
2025-09-26	BUY	6,908	78.960	77.694	77.821	GBX 537,587	88.87
2025-09-25	BUY	483	79.875	77.600	77.827	GBX 37,591	88.93
2025-09-24	BUY	9,156	80.115	79.330	79.409	GBX 727,064	88.97
2025-09-18	BUY	1,932			81.530*		89.01
2025-09-17	BUY	2,415			81.140*		89.05
2025-09-16	BUY	3,864			81.090*		89.09
2025-09-11	SELL	-160			85.150*		89.11 Profit of 14,258 on sale
2025-09-10	BUY	10,240			84.030*		89.14
2025-09-09	BUY	632			84.610*		89.16
2025-08-06	BUY	3,016	81.320	79.270	79.475	GBX 239,697	89.26
2025-07-31	BUY	805	81.490	77.850	78.214	GBX 62,962	89.36
2025-07-29	BUY	3,220	82.890	76.660	77.283	GBX 248,851	89.44
2025-07-28	BUY	632	84.970	83.870	83.980	GBX 53,075	89.47
2025-07-25	BUY	966	85.220	83.840	83.978	GBX 81,123	89.49
2025-07-24	BUY	470	84.510	83.520	83.619	GBX 39,301	89.52
2025-07-23	BUY	1,127	84.140	82.410	82.583	GBX 93,071	89.55
2025-07-22	BUY	644	81.770	79.870	80.060	GBX 51,559	89.59
2025-07-18	BUY	1,256	81.920	79.860	80.066	GBX 100,563	89.65
2025-07-17	BUY	966	82.660	81.340	81.472	GBX 78,702	89.69
2025-07-11	BUY	1,288	84.130	82.260	82.447	GBX 106,192	89.85
2025-07-10	BUY	1,449	85.000	83.170	83.353	GBX 120,778	89.88
2025-07-09	BUY	1,449	84.480	81.890	82.149	GBX 119,034	89.92
2025-07-07	SELL	-966	81.540	80.150	80.289	GBX -77,559	90.02 Profit of 9,399 on sale
2025-07-02	SELL	-3,991	82.790	81.894	81.983	GBX -327,195	90.17 Profit of 32,676 on sale
2025-06-27	BUY	463	79.540	78.140	78.280	GBX 36,244	90.30
2025-06-26	BUY	483	80.250	78.370	78.558	GBX 37,944	90.37
2025-06-24	SELL	-2,254	81.460	79.090	79.327	GBX -178,803	90.50 Profit of 25,176 on sale
2025-06-18	BUY	1,288	80.310	77.100	77.421	GBX 99,718	90.77
2025-06-17	BUY	483	80.700	78.190	78.441	GBX 37,887	90.85
2025-06-16	SELL	-657	81.350	79.710	79.874	GBX -52,477	90.91 Profit of 7,251 on sale
2025-06-13	BUY	1,380	82.440	81.450	81.549	GBX 112,538	90.97
2025-06-12	SELL	-805	82.110	80.070	80.274	GBX -64,621	91.03 Profit of 8,657 on sale
2025-06-11	BUY	1,715	81.680	79.980	80.150	GBX 137,457	91.10
2025-06-06	BUY	483	79.490	78.210	78.338	GBX 37,837	91.32
2025-06-05	BUY	2,254	78.550	77.250	77.380	GBX 174,415	91.41
2025-06-04	BUY	320	79.140	77.330	77.511	GBX 24,804	91.49
2025-06-03	SELL	-160	77.185	75.435	75.610	GBX -12,098	91.59 Profit of 2,557 on sale
2025-05-30	SELL	-19,520			76.840*		91.79 Profit of 1,791,786 on sale
2025-05-29	BUY	436			76.400*		91.90
2025-05-27	BUY	2,762	78.200	77.050	77.165	GBX 213,130	92.10
2025-05-23	BUY	2,235			77.580*		92.31
2025-05-22	BUY	1,120	78.360	76.680	76.848	GBX 86,070	92.41
2025-05-19	BUY	960			77.230*		92.73
2025-05-16	BUY	480	76.165	74.368	74.547	GBX 35,783	92.85
2025-05-15	SELL	-320			74.800*		92.99 Profit of 29,755 on sale
2025-05-14	BUY	160			73.470*		93.13
2025-05-13	BUY	320			76.630*		93.25
2025-05-12	BUY	1,085			80.430*		93.35
2025-05-09	SELL	-800			75.970*		93.48 Profit of 74,782 on sale
2025-05-08	BUY	320			77.650*		93.60
2025-05-07	BUY	480			79.120*		93.71
2025-05-02	BUY	17,760	84.710	82.950	83.126	GBX 1,476,318	93.99
2025-04-30	BUY	5,600	85.830	83.790	83.994	GBX 470,366	94.15
2025-04-29	BUY	1,407	85.690	82.750	83.044	GBX 116,843	94.22
2025-04-28	BUY	1,120	83.680	82.400	82.528	GBX 92,431	94.31
2025-04-25	BUY	2,880	83.280	78.060	78.582	GBX 226,316	94.40
2025-04-24	SELL	-3,360	79.970	76.030	76.424	GBX -256,785	94.52 Profit of 60,812 on sale
2025-04-23	BUY	3,040	80.200	78.240	78.436	GBX 238,445	94.65
2025-04-22	BUY	1,280	79.035	77.660	77.798	GBX 99,581	94.78
2025-04-17	BUY	1,760	78.746	76.880	77.067	GBX 135,637	95.22
2025-04-17	BUY	1,760	78.746	76.880	77.067	GBX 135,637	95.22
2025-04-15	BUY	1,600	79.960	77.720	77.944	GBX 124,710	95.53
2025-04-11	BUY	2,560	79.440	76.360	76.668	GBX 196,270	95.81
2025-04-09	BUY	960	81.990	76.000	76.599	GBX 73,535	96.10
2025-04-08	BUY	5,760	83.270	77.540	78.113	GBX 449,931	96.26
2025-04-07	BUY	1,887	83.210	79.300	79.691	GBX 150,377	96.40
2025-04-04	SELL	-2,560	86.260	81.090	81.607	GBX -208,914	96.54 Profit of 38,220 on sale
2025-04-02	BUY	21,760			86.600*		96.63
2025-04-01	BUY	160			87.120*		96.72
2025-03-31	BUY	1,120			89.760*		96.79
2025-03-28	BUY	640			89.230*		96.86
2025-03-27	BUY	298			87.600*		96.95
2025-03-26	BUY	160			88.110*		97.03
2025-03-25	BUY	1,730			87.870*		97.13
2025-03-24	BUY	1,937			92.310*		97.17
2025-03-21	SELL	-640			93.110*		97.21 Profit of 62,217 on sale
2025-03-20	BUY	2,560			94.730*		97.24
2025-03-19	BUY	447			94.020*		97.27
2025-03-18	BUY	5,540			94.720*		97.30
2025-03-17	BUY	1,120			94.790*		97.33
2025-03-14	BUY	8,320			94.570*		97.36
2025-03-13	BUY	1,600			94.710*		97.38
2025-03-12	SELL	-8,000			93.350*		97.43 Profit of 779,423 on sale
2025-03-11	SELL	-5,920			94.730*		97.46 Profit of 576,949 on sale
2025-03-10	BUY	1,760			95.230*		97.48
2025-03-07	BUY	320			94.650*		97.51
2025-03-05	BUY	2,400			93.190*		97.56
2025-03-04	BUY	2,720			92.560*		97.62
2025-03-03	BUY	5,120	92.790	91.810	91.908	GBX 470,569	97.67
2025-02-28	BUY	4,160	92.350	90.710	90.874	GBX 378,036	97.74
2025-02-27	SELL	-800	90.970	89.250	89.422	GBX -71,538	97.82 Profit of 6,720 on sale
2025-02-25	BUY	5,920	93.060	90.440	90.702	GBX 536,956	98.00
2025-02-21	BUY	640	89.530	87.010	87.262	GBX 55,848	98.19
2025-02-18	SELL	-1,440	83.590	81.040	81.295	GBX -117,065	98.69 Profit of 25,044 on sale
2025-02-14	SELL	-9,760	84.760	82.094	82.361	GBX -803,839	99.10 Profit of 163,424 on sale
2025-02-13	BUY	160	85.690	84.310	84.448	GBX 13,512	99.30
2025-02-12	BUY	1,578	86.670	85.610	85.716	GBX 135,260	99.49
2025-02-07	SELL	-215	88.600	87.120	87.268	GBX -18,763	100.04 Profit of 2,745 on sale
2025-02-06	BUY	3,040	89.571	87.840	88.013	GBX 267,560	100.21
2025-02-05	BUY	800	90.740	87.995	88.270	GBX 70,616	100.37
2025-02-04	BUY	960	91.230	87.330	87.720	GBX 84,211	100.51
2025-02-03	BUY	960	100.145	98.000	98.214	GBX 94,286	100.52
2025-01-31	BUY	1,760	100.060	98.580	98.728	GBX 173,761	100.55
2025-01-29	SELL	-160	99.150	97.390	97.566	GBX -15,611	100.61 Profit of 487 on sale
2025-01-28	SELL	-1,440	98.880	96.590	96.819	GBX -139,419	100.66 Profit of 5,528 on sale
2025-01-27	SELL	-2,560	98.620	95.990	96.253	GBX -246,408	100.70 Profit of 11,391 on sale
2025-01-24	BUY	1,920	97.100	95.410	95.579	GBX 183,512	100.79
2025-01-23	BUY	320	97.155	95.230	95.423	GBX 30,535	100.86
2025-01-22	BUY	2,643	97.000	95.150	95.335	GBX 251,970	100.95
2025-01-21	BUY	1,920	98.270	95.760	96.011	GBX 184,341	101.03
2025-01-16	BUY	2,991	100.895	99.950	100.044	GBX 299,233	101.15
2025-01-14	BUY	1,280	101.490	99.020	99.267	GBX 127,062	101.20
2025-01-10	BUY	3,840	100.405	98.810	98.969	GBX 380,043	101.25
2024-12-30	BUY	480	99.570	98.270	98.400	GBX 47,232	101.46
2024-12-27	BUY	640	100.350	99.246	99.356	GBX 63,588	101.50
2024-12-23	BUY	4,800	99.590	98.201	98.340	GBX 472,031	101.64
2024-12-20	BUY	1,280	99.671	97.900	98.077	GBX 125,539	101.73
2024-12-19	BUY	160	99.935	97.820	98.031	GBX 15,685	101.78
2024-12-18	BUY	1,280	101.500	98.270	98.593	GBX 126,199	101.87
2024-12-17	BUY	320	100.800	99.360	99.504	GBX 31,841	101.92
2024-12-16	BUY	1,600	102.275	100.050	100.273	GBX 160,436	101.98
2024-12-13	BUY	1,170	102.570	100.530	100.734	GBX 117,859	101.97
2024-12-10	BUY	8,000	103.770	100.750	101.052	GBX 808,416	102.07
2024-12-09	BUY	960	105.070	102.330	102.604	GBX 98,500	102.02
2024-12-06	SELL	-2,400	103.950	102.690	102.816	GBX -246,758	101.98 Loss of -1,999 on sale
2024-12-05	SELL	-160	104.140	101.350	101.629	GBX -16,261	101.93 Profit of 48 on sale
2024-12-03	BUY	800	102.450	100.620	100.803	GBX 80,642	101.95
2024-11-27	SELL	-960	103.450	101.640	101.821	GBX -97,748	101.93 Profit of 101 on sale
2024-11-26	BUY	3,360	101.800	99.700	99.910	GBX 335,698	101.94
2024-11-25	BUY	5,088	101.740	99.510	99.733	GBX 507,442	101.97
2024-11-22	SELL	-296	101.790	98.930	99.216	GBX -29,368	102.11 Profit of 856 on sale
2024-11-21	SELL	-795	100.480	96.950	97.303	GBX -77,356	102.22 Profit of 3,909 on sale
2024-11-20	SELL	-318	98.840	96.660	96.878	GBX -30,807	102.47 Profit of 1,779 on sale
2024-11-19	BUY	159	97.550	95.260	95.489	GBX 15,183	102.80
2024-11-18	BUY	1,336	97.290	95.420	95.607	GBX 127,731	103.17
2024-11-11	BUY	477	103.370	100.460	100.751	GBX 48,058	103.64
2024-11-07	BUY	433	101.690	100.850	100.934	GBX 43,704	103.88
2024-11-06	BUY	3,816	103.230	100.605	100.868	GBX 384,910	104.14
2024-11-05	BUY	795	101.730	100.520	100.641	GBX 80,010	104.37
2024-11-04	BUY	300	102.530	100.950	101.108	GBX 30,332	104.62
2024-11-01	BUY	444	102.720	101.210	101.361	GBX 45,004	104.93
2024-10-30	SELL	-954	105.000	102.900	103.110	GBX -98,367	105.31 Profit of 2,100 on sale
2024-10-29	SELL	-2,862	105.110	103.700	103.841	GBX -297,193	105.57 Profit of 4,963 on sale
2024-10-28	SELL	-1,113	105.000	103.930	104.037	GBX -115,793	105.84 Profit of 2,011 on sale
2024-10-21	SELL	-159	109.170	106.180	106.479	GBX -16,930	0.00 Loss of -16,930 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer